Friday, July 10, 2026

Drug profile · INN

nomegestrol

nomegestrol (ZOELY) is a progesterone receptor agonist.

EMA: approved Genito-urinary system and sex hormones (G03) G03AA14
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — nomegestrol
Class
Genito-urinary system and sex hormones (G03)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

nomegestrol (ZOELY) is a progesterone receptor agonist.

Key facts

INN nomegestrol
Brand ZOELY
Mechanism Progesterone receptor agonist
Target Progesterone receptor
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03AA14

Mechanism of action

Progesterone receptor agonist

Primary target: Progesterone receptor

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. apomorphine Genito-urinary system and sex hormones (G04)
  2. desogestrel Progesterone receptor agonist
  3. medroxyprogesterone acetate Progesterone receptor agonist
  4. megestrol acetate Progesterone receptor agonist
  5. mirabegron Genito-urinary system and sex hormones (G04)
  6. norethindrone Progesterone receptor agonist

Frequently asked questions

What is nomegestrol?

nomegestrol (ZOELY) is a progesterone receptor agonist.

What is the brand name for nomegestrol?

ZOELY is a marketed brand name for nomegestrol. Check FDA Drugs@FDA for the current US label holder and prescribing information.